Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Working Capital/Sales

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
AD     Remove this Ad

AUROBINDO PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 5.095.175.104.845.35

What is the latest Working Capital/Sales ratio of AUROBINDO PHARMA ?

The latest Working Capital/Sales ratio of AUROBINDO PHARMA is 5.09 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20255.09
Mar20245.17
Mar20235.10
Mar20224.84
Mar20215.35

How is Working Capital/Sales of AUROBINDO PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 5.09
-1.55
Mar2024 5.17
1.37
Mar2023 5.1
5.37
Mar2022 4.84
-9.53
Mar2021 5.35 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Working Capital/Sales ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹77,592.0 Cr 2.2% 9.4% 16% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

2.2%

9.4%

16%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses